Corbus Pharmaceuticals Holdings, Inc. financial data

Symbol
CRBP on Nasdaq
Location
500 River Ridge Drive, Norwood, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 967 % +98.9%
Debt-to-equity 12.2 % -57%
Return On Equity -57.1 % -35.1%
Return On Assets -50.9 % -54.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares +44.1%
Common Stock, Shares, Outstanding 12.5M shares +2.92%
Entity Public Float 428M USD +1138%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 12.3M shares +2.44%
Weighted Average Number of Shares Outstanding, Diluted 12.3M shares +2.44%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 60.5M USD +98.8%
General and Administrative Expense 15.5M USD -2.1%
Operating Income (Loss) -75.9M USD -64.3%
Nonoperating Income (Expense) 8.44M USD +12.2%
Net Income (Loss) Attributable to Parent -67.5M USD -74.4%
Earnings Per Share, Basic -5 USD/shares -19.4%
Earnings Per Share, Diluted -5 USD/shares -19.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27M USD +38.9%
Assets, Current 108M USD -33.1%
Property, Plant and Equipment, Net 201K USD -61.3%
Operating Lease, Right-of-Use Asset 1.36M USD -42.9%
Other Assets, Noncurrent 0 USD -100%
Assets 110M USD -33.3%
Accounts Payable, Current 2.74M USD -5.09%
Employee-related Liabilities, Current 2.41M USD +32.4%
Accrued Liabilities, Current 12.6M USD +75.3%
Liabilities, Current 17.1M USD +46.8%
Operating Lease, Liability, Noncurrent 307K USD -85%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 17.4M USD +27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3K USD -101%
Retained Earnings (Accumulated Deficit) -535M USD -14.4%
Stockholders' Equity Attributable to Parent 92.1M USD -38.8%
Liabilities and Equity 110M USD -33.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.4M USD -106%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 18.1M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 12.5M shares +2.92%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.7M USD +349%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.7M USD +37.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 106M USD +11.3%
Deferred Tax Assets, Gross 106M USD +11.3%
Operating Lease, Liability 2.05M USD -43.2%
Depreciation 300K USD -51.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -67.7M USD -76%
Lessee, Operating Lease, Liability, to be Paid 2.14M USD -45.5%
Property, Plant and Equipment, Gross 4.46M USD -1.57%
Operating Lease, Liability, Current 1.74M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.69M USD -5.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 451K USD +2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 90K USD -71.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.69M USD -5.96%
Deferred Tax Assets, Operating Loss Carryforwards 63.1M USD +6.72%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.69M USD 0%
Additional Paid in Capital 627M USD +1.52%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9.71M USD
Interest Expense 652K USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%